Clinical Trial

Clinical Utility of Preoperative Thyroid GuidePx® Testing

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn whether having Thyroid GuidePx® test results available before treatment may help patients with papillary thyroid cancer and doctors make better-informed treatment decisions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-07.
Trial Details
NCT Number NCT07584447
Lead Sponsor University of Calgary
Collaborators: Qualisure Diagnostics Inc., University of Alberta
Conditions Papillary Thyroid Cancer, Papillary Thyroid Carcinoma
Enrollment 85 participants
Start Date 2026-04
Primary Completion 2028-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-01